Immunogenicity and Safety of Adacel Polio Vaccine

Summary

The present study is designed to meet the requirements of the Taiwanese Health Authorities for registration of ADACEL POLIO in Taiwan. Subjects will receive one dose of the study vaccine at 6 to 8 years of age. Blood samples will be taken for antibody titration. The expected total duration of follow-up for each subject will be 28 days.

Timeline

Start

2008-11

Primary completion

2009-04

Completion

2009-07

Drugs

Indications